Kelvin M. Neu
Independent DirectorDr. Kelvin M. Neu, M.D., Ph.D., has been an Independent Director of Zymeworks Inc. since March 16, 2020. He also serves as Managing Director of Baker Brothers Investments. He served as Independent Director of Prelude Therapeutics Inc. until January 25, 2021. Dr. Neu is Founder and Chief of Herringbone, a life sciences innovation practice established in January 2022. Dr. Neu is also Co-Founder and Chair of QDX Technologies Pte. Ltd. and QDX Pte Ltd., a computational chemistry company established in February 2023 nd XBI Biosciences LLC (a therapeutics development company). Dr. Neu was a Partner at Baker BrothersAdvisors LP, a registered investment adviser, where he worked from April 2004 until January 2021. He was Independent Directors at IGM Biosciences Inc. since June 2019 until January 26, 2021. Dr. Neu was trained as a physician-scientist. He served as an Associate and Director of Baker Bros. Advisors LP. He served as Director of Idera Pharmaceuticals, Inc. since March 10, 2014 until June 4, 2019. He served as Director of Neoleukin Therapeutics, Inc. (Formerly kwon as Aquinox Pharmaceuticals, Inc.) since March 2017 until August 2019. He served a Director of XOMA Corporation since July 19, 2012. He served as a Director of Presidio Pharmaceuticals, Inc. Dr. Neu served as an Independent Director of Anormed Inc. since April 21, 2006 and diaDexus, Inc. since December 2005. Prior to attending Princeton, Dr. Neu served for few years in the military of his native Singapore. He spent few years in the Immunology Ph.D. program at Stanford University as a Howard Hughes Medical Institute Fellow. Dr. Neu holds an M.D. from Harvard Medical School-MIT Health Sciences and Technology program. Dr. Neu also holds an A.B. (Summa Cum Laude) in Molecular Biology from Princeton University, where he was awarded the Khoury Prize for graduating first in his department of Molecular Biology.
Positions
- Company NameZymeworks Inc.Stock CodeZYMEPositionIndependent DirectorColleagues
- KHKenneth H. GalbraithChairman of the Board, CEO & President
- PAPaul A. MooreChief Scientific Officer
- SPScott PlatshonExecutive VP & Chief Business Officer
- KSKristin StaffordExecutive VP & CFO
- MHMark HollywoodExecutive VP & COO
- SMSusan M. MahonyLead Independent Director
- CECarlos E. CampoyIndependent Director
- GAGregory Austin CiongoliIndependent Director
